A Medicina Biomolecular foi regulamentada pelo Conselho Federal de Medicina na Resolução 1500/1998 e homologada na Resolução 1938/2010 com a assessoria da Associação Brasileira de Medicina Biomolecular.
 

Carnosina. Efeitos na Esclerose Lateral Amiotrófica (ELA) e na Polimiosite

 

                                 

           

05/03/2010

     Não esquecer da deficiência de vitamina D3 que acontece freqüentemente nestes pacientes.

The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases.

Stuerenburg HJ. Biochemistry (Mosc). 2000 Jul;65(7):862-5.

Neurological Department, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany. stuerenburg@uke.uni-hamburg.de.
Skeletal muscles undergo specific alterations that are related to the aging process. The incidence of several neuromuscular diseases (e.g., amyotrophic lateral sclerosis (ALS), myasthenia gravis, polymyositis, drug-induced myopathies, late-onset mitochondrial myopathy) is age-related. The increased sensitivity to disease of aging muscle represents an additional age-related negative influence in the presence of existing risk factors (such as a genetic predisposition). The potential significance of carnosine lies on one hand in its possible influence on specific physiological changes in muscle associated with the aging process, and on the other in its effect on oxidative stress and the antioxidative system in specific neuromuscular diseases such as ALS or polymyositis.
PMID: 10951106

 


   

 

 

 

© 2004 Associação Brasileira de Medicina Complementar. Todos os Direitos Reservados Rua Conde de Porto Alegre , 1985 - Campo Belo
São Paulo - SP - CEP: 04608-003
Tel.: 11-5093-5685